Fluorine in PDB 8pbo: Deep Interactome Learning For Generative Drug Design
Protein crystallography data
The structure of Deep Interactome Learning For Generative Drug Design, PDB code: 8pbo
was solved by
M.Hakansson,
D.Focht,
K.Atz,
G.Schneider,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.28 /
1.85
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
93.413,
60.611,
117.945,
90,
102.86,
90
|
R / Rfree (%)
|
17.1 /
21.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Deep Interactome Learning For Generative Drug Design
(pdb code 8pbo). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the
Deep Interactome Learning For Generative Drug Design, PDB code: 8pbo:
Jump to Fluorine binding site number:
1;
2;
Fluorine binding site 1 out
of 2 in 8pbo
Go back to
Fluorine Binding Sites List in 8pbo
Fluorine binding site 1 out
of 2 in the Deep Interactome Learning For Generative Drug Design
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Deep Interactome Learning For Generative Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:55.0
occ:1.00
|
F1
|
A:Y5I501
|
0.0
|
55.0
|
1.0
|
C18
|
A:Y5I501
|
1.4
|
42.2
|
1.0
|
C14
|
A:Y5I501
|
2.3
|
39.0
|
1.0
|
C19
|
A:Y5I501
|
2.4
|
45.5
|
1.0
|
H14
|
A:Y5I501
|
2.4
|
42.3
|
1.0
|
HE1
|
A:HIS449
|
2.5
|
37.5
|
1.0
|
H18
|
A:Y5I501
|
2.5
|
46.1
|
1.0
|
C15
|
A:Y5I501
|
2.8
|
42.6
|
1.0
|
HE2
|
A:LYS367
|
2.9
|
34.8
|
1.0
|
HD2
|
A:PHE363
|
2.9
|
47.5
|
1.0
|
CE1
|
A:HIS449
|
3.1
|
37.0
|
1.0
|
HE2
|
A:PHE363
|
3.2
|
47.2
|
1.0
|
HH
|
A:TYR327
|
3.3
|
32.6
|
0.0
|
H17
|
A:Y5I501
|
3.4
|
44.0
|
1.0
|
C13
|
A:Y5I501
|
3.6
|
43.1
|
1.0
|
C11
|
A:Y5I501
|
3.6
|
51.0
|
1.0
|
ND1
|
A:HIS449
|
3.6
|
36.5
|
1.0
|
H15
|
A:Y5I501
|
3.6
|
41.8
|
1.0
|
HE1
|
A:TYR327
|
3.6
|
33.0
|
1.0
|
HD1
|
A:HIS449
|
3.6
|
30.2
|
0.0
|
CD2
|
A:PHE363
|
3.7
|
50.5
|
1.0
|
C16
|
A:Y5I501
|
3.7
|
44.1
|
1.0
|
CE
|
A:LYS367
|
3.7
|
34.6
|
1.0
|
HB3
|
A:CYS285
|
3.8
|
35.4
|
1.0
|
HZ3
|
A:LYS367
|
3.8
|
38.1
|
1.0
|
CE2
|
A:PHE363
|
3.8
|
49.2
|
1.0
|
O
|
A:HOH669
|
3.8
|
50.7
|
1.0
|
HE3
|
A:LYS367
|
3.9
|
34.6
|
1.0
|
NE2
|
A:HIS449
|
4.0
|
40.0
|
1.0
|
C12
|
A:Y5I501
|
4.1
|
47.2
|
1.0
|
NZ
|
A:LYS367
|
4.1
|
39.3
|
1.0
|
OH
|
A:TYR327
|
4.1
|
37.5
|
1.0
|
HG
|
A:CYS285
|
4.1
|
33.5
|
0.0
|
HZ1
|
A:LYS367
|
4.2
|
38.2
|
1.0
|
H16
|
A:Y5I501
|
4.2
|
43.5
|
1.0
|
HE2
|
A:HIS449
|
4.2
|
33.4
|
0.0
|
HB2
|
A:CYS285
|
4.3
|
36.2
|
1.0
|
H13
|
A:Y5I501
|
4.3
|
43.0
|
1.0
|
CB
|
A:CYS285
|
4.4
|
35.3
|
1.0
|
CE1
|
A:TYR327
|
4.4
|
31.8
|
1.0
|
SD
|
A:MET364
|
4.6
|
48.8
|
1.0
|
HG2
|
A:LYS367
|
4.6
|
31.4
|
1.0
|
O2
|
A:Y5I501
|
4.7
|
47.6
|
1.0
|
CG
|
A:HIS449
|
4.7
|
35.8
|
1.0
|
CZ
|
A:TYR327
|
4.8
|
37.1
|
1.0
|
HE1
|
A:PHE282
|
4.8
|
44.6
|
1.0
|
O
|
A:PHE363
|
4.8
|
37.4
|
1.0
|
HB2
|
A:PHE363
|
4.9
|
38.3
|
1.0
|
C17
|
A:Y5I501
|
4.9
|
43.1
|
1.0
|
O
|
A:HOH605
|
4.9
|
52.9
|
1.0
|
CD
|
A:LYS367
|
4.9
|
31.7
|
1.0
|
CD2
|
A:HIS449
|
4.9
|
38.3
|
1.0
|
CG
|
A:PHE363
|
4.9
|
42.5
|
1.0
|
SG
|
A:CYS285
|
5.0
|
39.4
|
1.0
|
|
Fluorine binding site 2 out
of 2 in 8pbo
Go back to
Fluorine Binding Sites List in 8pbo
Fluorine binding site 2 out
of 2 in the Deep Interactome Learning For Generative Drug Design
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Deep Interactome Learning For Generative Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:65.7
occ:1.00
|
F2
|
A:Y5I501
|
0.0
|
65.7
|
1.0
|
C20
|
A:Y5I501
|
1.4
|
48.8
|
1.0
|
C21
|
A:Y5I501
|
2.3
|
52.5
|
1.0
|
C7
|
A:Y5I501
|
2.4
|
42.0
|
1.0
|
H19
|
A:Y5I501
|
2.5
|
50.6
|
1.0
|
O1
|
A:Y5I501
|
2.7
|
45.2
|
1.0
|
O
|
A:HOH691
|
2.9
|
47.5
|
1.0
|
HB2
|
A:ARG288
|
3.0
|
44.2
|
1.0
|
HA
|
A:CYS285
|
3.1
|
35.2
|
1.0
|
HB3
|
A:ARG288
|
3.3
|
43.8
|
1.0
|
O
|
A:GLY284
|
3.3
|
37.2
|
1.0
|
C
|
A:GLY284
|
3.6
|
45.6
|
1.0
|
CB
|
A:ARG288
|
3.6
|
42.2
|
1.0
|
O
|
A:HOH654
|
3.6
|
61.9
|
1.0
|
C4
|
A:Y5I501
|
3.6
|
46.6
|
1.0
|
C6
|
A:Y5I501
|
3.6
|
48.9
|
1.0
|
H11
|
A:Y5I501
|
3.6
|
46.9
|
1.0
|
HG2
|
A:ARG288
|
3.7
|
53.7
|
1.0
|
N
|
A:CYS285
|
3.8
|
37.4
|
1.0
|
CA
|
A:CYS285
|
3.9
|
34.1
|
1.0
|
C5
|
A:Y5I501
|
4.1
|
44.5
|
1.0
|
C8
|
A:Y5I501
|
4.1
|
42.7
|
1.0
|
CG
|
A:ARG288
|
4.2
|
55.3
|
1.0
|
HA3
|
A:GLY284
|
4.2
|
43.1
|
1.0
|
HB
|
A:ILE341
|
4.2
|
36.1
|
1.0
|
H
|
A:ARG288
|
4.3
|
38.3
|
1.0
|
HD2
|
A:ARG288
|
4.4
|
66.5
|
1.0
|
H
|
A:CYS285
|
4.4
|
38.8
|
1.0
|
H5
|
A:Y5I501
|
4.4
|
46.0
|
1.0
|
HG22
|
A:ILE341
|
4.4
|
37.2
|
1.0
|
CA
|
A:GLY284
|
4.4
|
43.3
|
1.0
|
C10
|
A:Y5I501
|
4.5
|
47.4
|
1.0
|
SG
|
A:CYS285
|
4.5
|
39.4
|
1.0
|
H7
|
A:Y5I501
|
4.5
|
43.8
|
1.0
|
H6
|
A:Y5I501
|
4.6
|
43.9
|
1.0
|
H9
|
A:Y5I501
|
4.6
|
44.2
|
1.0
|
C9
|
A:Y5I501
|
4.7
|
44.0
|
1.0
|
H
|
A:SER342
|
4.7
|
38.1
|
1.0
|
HG23
|
A:ILE341
|
4.7
|
38.0
|
1.0
|
O
|
A:HOH651
|
4.7
|
45.0
|
1.0
|
HA2
|
A:GLY284
|
4.8
|
43.4
|
1.0
|
C3
|
A:Y5I501
|
4.8
|
58.8
|
1.0
|
H10
|
A:Y5I501
|
4.8
|
46.3
|
1.0
|
CB
|
A:CYS285
|
4.8
|
35.3
|
1.0
|
CA
|
A:ARG288
|
4.9
|
38.2
|
1.0
|
CD
|
A:ARG288
|
4.9
|
66.2
|
1.0
|
C
|
A:CYS285
|
4.9
|
38.4
|
1.0
|
CG2
|
A:ILE341
|
4.9
|
38.7
|
1.0
|
N
|
A:ARG288
|
4.9
|
36.4
|
1.0
|
HG3
|
A:ARG288
|
5.0
|
53.5
|
1.0
|
|
Reference:
K.Atz,
L.Cotos,
C.Isert,
M.Hakansson,
D.Focht,
M.Hilleke,
D.F.Nippa,
M.Iff,
J.Ledergerber,
C.C.G.Schiebroek,
V.Romeo,
J.A.Hiss,
D.Merk,
P.Schneider,
B.Kuhn,
U.Grether,
G.Schneider.
Prospective De Novo Drug Design with Deep Interactome Learning. Nat Commun V. 15 3408 2024.
ISSN: ESSN 2041-1723
PubMed: 38649351
DOI: 10.1038/S41467-024-47613-W
Page generated: Fri Aug 2 21:57:42 2024
|